Search
REGOR 35 MG, Comprimé pelliculé
Details
| --- | Description |
|---|---|
| Pack | Boite de 12 |
| Strength (Dosage) | 35 MG |
| Laboratory | PHARMIS |
| Ingredients | Risédronate |
| Therapeutic class | Régulateur du métabolisme osseux, bisphosphonate |
| ATC code | M05BA07 |
| PPH | $31.20 |
| PPV | $47.20 |
| Refundable | Yes |
| Refund base | $47.20 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | · Traitement de l'ostéoporose post-ménopausique pour réduire le risque de fractures vertébrales. · Traitement de l'ostéoporose post-ménopausique avérée, pour réduire le risque de fractures de hanche. · Traitement de l'ostéoporose chez l'homme à haut risque de fracture. |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications with one or more of the ingredients above
Medications under one or more of the therapeutic classes above
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem